FDA Proposes Electronic Labeling Format for Human Prescription Drugs and Biologics

Summary

The Food and Drug Administration (FDA) is proposing to require certain labeling content for human prescription drugs and biologics to be submitted electronically, aiming to simplify the review process and speed up approval of labeling changes.